Sudarshan Chemical Industries Limited
NSE: SUDARSCHEM | Information Technology
Market Fundamentals
Stock Intelligence & News
Tata Comms, Siemens, Aadhar Housing, Styrenix, Sudarshan — Top 5 stocks to buy on Monday | Target, SL by Sumeet Bagadia
Stock market prediction: Sumeet Bagadia believes Dalal Street bias has further weakened, as the Nifty 50 index is approaching its near-term support at 22,200
Read Full Analysis →Sudarshan Pharma Industries Ltd (543828)
The Trading Window of the Company shall remain closed with effect from October 1,2026 until the expiry of 48 hours after the declaration of financial results for the quarter and half year ended 30/Sept/2026.
Read Full Analysis →Rainbow Children's Medicare Ltd (543524)
Outcome of Board Meeting for Appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) of the Company and other general matters
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Sudarshan Pharma Industries Ltd (543828)
Pursuant to Reg 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of the Company letter no. SPIL/CS/2026-2027/57 dated 5th September 2026, this is to inform you that the proposal to acquire 9.50% equity shares of common stock of Med Therapy Biotechnology INC., USA is under due diligence as well as confirmation from Med Therapy Board of Directors decision and Board of Directors Resolution is also pending. Hence, proposal was intimated only and the Company will come back with updates at the earliest possible time.
Read Full Analysis →350% rally in 3 years, multibagger pharma stock to be in focus on Wednesday | Key details from filing
Sudarshan Pharma Industries is under due diligence for acquiring a 9.50% stake in MedTherapy Biotechnology. This includes a 1.50% stake from its promoters. The acquisition aims to enhance its US market presence, with completion expected by March 2027.
Read Full Analysis →Sudarshan Colorants India Limited
Sudarshan Colorants India Limited has informed the Exchange about Action(s) taken or orders passed |SUBJECT: Action(s) taken or orders passed
Read Full Analysis →Sudarshan Chemical Industries Ltd (506655)
Announcement under Reg 30 - Credit Rating
Read Full Analysis →Sudarshan Chemical Industries Limited
Sudarshan Chemical Industries Limited has informed the Exchange about General Updateswe wish to inform you that Crisil ESG Ratings & Analytics Limited, on 10th September, 2026, has voluntarily assigned a rating of Crisil ESG 53 and a Core ESG rating of Crisil Core ESG 55 based on data pertaining to the Financial Year 2025-26.We further inform that the Company has not engaged Crisil ESG Ratings & Analytics Limited. They have independently determined the ESG score based on the public disclosures made by the Company and publicly available information pertaining to the Financial Year 2025-26 |SUBJECT: General Updates
Read Full Analysis →Sudarshan Chemical Industries Ltd (506655)
Submission of ESG Rating given by Crisil ESG Ratings and Analytics Limited
Read Full Analysis →Sudarshan Pharma Industries Ltd (543828)
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta
Read Full Analysis →Get instant alerts when SUDARSCHEM breaks news
Join investors who track Sudarshan Chemical Industries Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SUDARSCHEM?
SUDARSCHEM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Sudarshan Chemical Industries Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SUDARSCHEM to your custom watchlist.